Close
Close
CJC-1295 / Ipamorelin

CJC-1295 / Ipamorelin 3-Month Membership Program

$1,050.00

4.9 Avg. Rating

1000+ Reviews

  • Follow-up Exam
  • Lab Review
  • Dose Adjustments
  • Certificate of Authenticity
  • 503A Pharmacies
  • 99% Pure
  • US-based Peptides
CJC-1295 and Ipamorelin are two peptides that are often prescribed together because they work well as a team. Both are designed to support the body’s own natural production of growth hormone, rather than replacing it directly. This is one of the main reasons patients ask about this combination instead of other options.
Growth hormone is a substance your body already makes, mostly while you sleep. It plays a role in how your body repairs tissue, maintains muscle, and manages metabolism. As people get older, natural growth hormone production tends to slow down. This is a normal part of aging, but it is also why many adults become curious about ways to support healthy hormone levels as they age.
CJC-1295 belongs to a class of peptides known as growth hormone releasing hormone (GHRH) analogs. Ipamorelin belongs to a different class called growth hormone releasing peptides (GHRPs). When used together, they are thought to support growth hormone release through two different signaling pathways in the body, which is why many providers consider the combination rather than using either peptide alone.
Patients typically ask about CJC-1295 / Ipamorelin when they are interested in recovery, healthy aging, or general wellness support. It is not a weight loss medication and is not intended to replace a healthy lifestyle, proper sleep, or medical treatment for a diagnosed condition.
It’s important to understand that individual responses to peptide therapy can vary, and this combination is best considered as part of a broader, medically supervised wellness plan.
Think of your pituitary gland, a small gland at the base of your brain, as a factory that produces growth hormone. As we age, that factory can slow down its shifts. CJC-1295 and Ipamorelin are designed to send different “start work” signals to that factory. CJC-1295 sends a steady, gentle signal that encourages the pituitary gland to continue producing growth hormone over time. Ipamorelin sends a more immediate signal, similar to a quick reminder, that prompts a short pulse of growth hormone release. Because these two signals work through different pathways, using them together is thought to create a more complete and natural pattern of hormone release than either peptide might produce on its own. This approach is different from taking synthetic growth hormone directly. Instead of adding growth hormone from an outside source, these peptides are intended to encourage the body to produce more of its own.
  • May support the body’s natural growth hormone production
  • May help promote improved sleep quality for some patients
  • Commonly used to support recovery after exercise or physical activity
  • May assist with the maintenance of lean muscle mass
  • Has shown promise in research related to tissue repair processes
  • May support healthy aging goals as part of a broader wellness plan
  • May help promote a general sense of improved energy for some patients
Evidence for these benefits varies in strength, and not every patient will experience the same results.
People who commonly ask about CJC-1295 / Ipamorelin include:
  • Adults interested in healthy aging and longevity-focused wellness
  • Active individuals looking for additional support with exercise recovery
  • Patients focused on maintaining muscle as part of an overall wellness plan
  • Adults who are curious about supporting their body’s natural hormone patterns
  • Patients already engaged in a wellness optimization plan with their provider
This therapy is not appropriate for everyone, and it is not intended for anyone seeking rapid or dramatic changes to body composition. A medical evaluation is necessary to determine whether this option fits your specific health history and goals.
Research on growth hormone releasing peptides like CJC-1295 and Ipamorelin includes both laboratory and human studies, particularly around their ability to stimulate growth hormone release. Some human studies have looked at how these peptides affect growth hormone and related markers in the body, and animal studies have explored broader effects on tissue and metabolism. That said, research in this area continues to evolve. Many studies involve small groups of participants, and longer-term human studies are still limited compared to more established hormone treatments. Much of what is understood about the combined use of CJC-1295 and Ipamorelin is based on how each peptide performs individually, along with clinical experience, rather than large-scale combination trials. Because individual biology, age, activity level, and overall health all play a role in how someone responds, results can differ significantly from person to person. Ongoing research continues to explore optimal use, long-term safety, and the full range of potential benefits.
As with any peptide therapy, CJC-1295 / Ipamorelin should only be used under the guidance of a licensed healthcare provider following an appropriate medical evaluation. Possible side effects can include injection site reactions, headache, flushing, mild water retention, or temporary changes in appetite. Some patients report mild dizziness or lightheadedness, particularly when first starting therapy. This peptide combination may not be an appropriate choice for individuals with a history of certain hormone-sensitive conditions, active cancer, or other significant medical conditions. Your provider will review your full medical history, including current medications and any past diagnoses, before determining whether this therapy is suitable for you. Medical supervision is important throughout treatment, not just at the start. Growth hormone pathways can influence multiple body systems, so ongoing monitoring helps your provider adjust your plan as needed and watch for any signs that treatment should be modified. Following your prescribed treatment plan, including dosing and follow-up appointments, helps support both safety and the likelihood of a positive experience.

What does CJC-1295 / Ipamorelin do?

It is designed to support your body’s natural production of growth hormone by sending two different signals to the pituitary gland.

How long before I may notice changes?

This varies by patient. Some people report changes in sleep or recovery within several weeks, while other effects may take longer to notice. Individual results vary.

Is it an injection?

Yes, CJC-1295 / Ipamorelin is typically administered as a subcutaneous injection, usually at home after proper training from your provider.

Can it be combined with other peptides?

In some cases, providers may combine this therapy with other peptides based on a patient’s specific goals and medical history. This decision is made on an individual basis.

Can it be combined with GLP-1 medications?

Some patients use growth hormone peptide therapy alongside GLP-1 medications under medical supervision. Whether this is appropriate for you depends on your full health picture, which your provider will review.

Will I need lab work?

Your provider may recommend baseline or follow-up lab work depending on your health history and treatment goals.

Who should avoid this peptide?

Individuals with certain hormone-sensitive conditions, active cancer, or specific medical conditions may not be appropriate candidates. A full medical evaluation is required to determine eligibility.

How long do patients typically remain on therapy?

Treatment length varies based on individual goals and provider recommendations. Many programs are structured around a three-month treatment and follow-up cycle.

Is a consultation required?

Yes. A telehealth consultation with a licensed provider is required before any peptide therapy can be prescribed.

Will this replace a healthy lifestyle?

No. Peptide therapy is intended to complement, not replace, good sleep habits, nutrition, and physical activity.
Every peptide treatment program at LeadWest Medical is designed to be thorough, transparent, and centered on your individual needs. When you begin CJC-1295 / Ipamorelin therapy with us, your treatment program includes:
  • An initial telehealth medical history and comprehensive evaluation with a licensed medical provider
  • Review of previous laboratory results when available, or recommendations for laboratory testing when medically appropriate
  • Personalized treatment recommendations based on your medical history and goals
  • Three months of prescribed peptide therapy when medically appropriate
  • A customized dosing and titration schedule specific to your prescribed peptide
  • A comprehensive follow-up appointment approximately three months after starting treatment
  • Review of progress, discussion of results, treatment adjustments if medically appropriate, and continued provider guidance
  • Ongoing provider oversight throughout your treatment program
  • No additional fees for appointments included within the treatment program
  • No additional fees for laboratory review as part of your treatment
Our goal at LeadWest Medical is to make peptide therapy simple, transparent, and medically supervised from your very first consultation through your follow-up care, so you always know what to expect and always have a provider guiding you along the way.
LeadWest Medical focuses on individualized care rather than one-size-fits-all treatment plans. Every patient’s history, goals, and needs are different, and we believe treatment plans should reflect that. Patients choose LeadWest Medical because we offer:
  • Personalized treatment plans built around each patient’s health history and goals
  • Licensed medical providers overseeing every step of care
  • Provider-guided dosing rather than generic protocols
  • Peptides sourced through FDA-registered 503A U.S. compounding pharmacies that follow applicable quality standards
  • Ongoing medical supervision throughout the treatment period
  • A structured three-month follow-up built into every program
  • Transparent pricing, with no surprise appointment or lab review fees within the treatment program
  • CJC-1295 / Ipamorelin is a combination peptide therapy designed to support the body’s natural growth hormone production.
  • CJC-1295 and Ipamorelin work through two different signaling pathways to the pituitary gland.
  • This therapy is commonly explored for recovery, healthy aging, and general wellness support.
  • Research shows promise, but long-term human studies remain limited and continue to evolve.
  • Individual results vary, and this is not a guaranteed or universal solution.
  • Medical supervision, including a full evaluation and ongoing monitoring, is essential for safe use.
  • This therapy works best as part of a broader wellness plan that includes good sleep, nutrition, and activity.
  • A licensed provider consultation is required before starting treatment.

Educational Disclaimer

This information is provided for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Peptide therapy should only be used under the supervision of a licensed healthcare provider after an appropriate medical evaluation. Individual results may vary.

$100 OFF GLP-1 Injectable Plans for New Members ! CODE: